---
title: "\"Performance\" GROWN UP GROUP's interim loss expands to 8.47 million yuan"
description: "GROWN UP GROUP announced its interim results for the six months ended June, with revenue recorded at HKD 147 million, a year-on-year decrease of 2.6%. The loss expanded from HKD 5.75 million in the sa"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/254311780.md"
published_at: "2025-08-24T09:07:11.000Z"
---

# "Performance" GROWN UP GROUP's interim loss expands to 8.47 million yuan

> GROWN UP GROUP announced its interim results for the six months ended June, with revenue recorded at HKD 147 million, a year-on-year decrease of 2.6%. The loss expanded from HKD 5.75 million in the same period last year to HKD 8.47 million, with a loss per share of 0.71 cents. No dividend was declared

GROWN UP GROUP (01842.HK) announced its interim results for the six months ending in June, with revenue recorded at HKD 147 million, a year-on-year decrease of 2.6%. The loss expanded from HKD 5.75 million in the same period last year to HKD 8.47 million, with a loss per share of HKD 0.0071. No dividend was declared

### Related Stocks

- [01842.HK - GROWN UP GROUP](https://longbridge.com/en/quote/01842.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Amazon, Google And Others Are Pouring $700 Billion Into AI CapEx, Top Analyst Explains Why This Makes It 'Hard' To Bet Against Nvidia | Amazon, Microsoft, Meta, Tesla, Apple, and Google are set to invest nearly $700 billion in AI-driven capital expenditure | [Link](https://longbridge.com/en/news/275700100.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/en/news/276035104.md) |
| Prediction: This AI Stock Will Soar After Feb. 25. Here's Why. | Nvidia (NVDA) shares have faced a 2% decline over the past three months due to geopolitical tensions and concerns about  | [Link](https://longbridge.com/en/news/275701772.md) |
| CSPC Pharmaceutical Group Receives FDA Approval for SYH2082 Clinical Trial in the US | CSPC Pharmaceutical Group Ltd. has received FDA approval to conduct clinical trials for SYH2082, a GLP-1/GIP receptor du | [Link](https://longbridge.com/en/news/276033771.md) |
| Lenovo Caught Napping By 'Democratization Of AI' | Lenovo reported a 21% profit decline in its latest fiscal quarter, taking a $285 million restructuring charge due to a s | [Link](https://longbridge.com/en/news/275904944.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
